Arbutus Biopharma
ABUS
#6201
Rank
A$1.26 B
Marketcap
A$6.49
Share price
-0.88%
Change (1 day)
16.75%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): A-$0.40

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A-$0.38. In 2024 the company made an earnings per share (EPS) of A-$0.55 an increase over its 2023 EPS that were of A-$0.64.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.40-27.62%
2024A-$0.55-13.64%
2023A-$0.64-4.35%
2022A-$0.67-44.58%
2021A-$1.20-17%
2020A-$1.45-65.4%
2019A-$4.18138.84%
2018A-$1.75-22.44%
2017A-$2.26-78.45%
2016A-$10.48424.64%
2015A-$2.00-20.19%
2014A-$2.5087.96%
2013A-$1.33-142.59%
2012A$3.13-342.7%
2011A-$1.29-25.82%
2010A-$1.7447.8%
2009A-$1.18-43.55%
2008A-$2.08158.91%
2007A-$0.80-111.88%
2006A$6.77-552.53%
2005A-$1.50-71.77%
2004A-$5.30-14.48%
2003A-$6.20-8.95%
2002A-$6.8070.07%
2001A-$4.0048.01%
2000A-$2.70-38.54%
1999A-$4.40-24.6%
1998A-$5.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.08686-76.92% Bahamas
NRC Health
NRC
A$1.01-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA